Skip to content

Perspective Therapeutics CATX Total Current Assets

Total Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$54.84B+32.9%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$353.1M+308%
Monopar Therapeutics logo
Monopar TherapeuticsMNPR
$137.74M+150%
Immunome logo
ImmunomeIMNM
$594.31M+83.9%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$784.74M+19.4%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$942.29M-33.8%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's total current assets?
Perspective Therapeutics (CATX) reported total current assets of $275.35M in Q1 2026.
How has Perspective Therapeutics's total current assets changed year-over-year?
Perspective Therapeutics's total current assets increased by 27.6% year-over-year, from $215.74M to $275.35M.
What is the long-term trend for Perspective Therapeutics's total current assets?
Over 5 years (2020 to 2025), Perspective Therapeutics's total current assets has grown at a 64.6% compound annual growth rate (CAGR), from $12.29M to $148.39M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.